Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India
· Delayed Price · Currency is INR 379.80
-3.15 (-0.82%)
May 9, 2025, 3:29 PM IST
NSE:INDRAMEDCO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 13,373 | 12,447 | 10,987 | 8,882 | 6,134 | 8,308 | Upgrade
|
| Revenue Growth (YoY) | 11.07% | 13.29% | 23.70% | 44.80% | -26.17% | 5.40% | Upgrade
|
| Cost of Revenue | 5,634 | 5,040 | 4,630 | 4,059 | 3,257 | 3,848 | Upgrade
|
| Gross Profit | 7,740 | 7,407 | 6,357 | 4,823 | 2,877 | 4,460 | Upgrade
|
| Selling, General & Admin | 1,066 | 1,066 | 894.6 | 552.1 | 284.5 | 509.79 | Upgrade
|
| Other Operating Expenses | 4,348 | 4,396 | 3,947 | 3,070 | 2,182 | 3,076 | Upgrade
|
| Operating Expenses | 5,850 | 5,863 | 5,234 | 3,972 | 2,800 | 3,915 | Upgrade
|
| Operating Income | 1,889 | 1,545 | 1,123 | 851.3 | 76.6 | 544.36 | Upgrade
|
| Interest Expense | -33.4 | -10.6 | -4.6 | -6.1 | - | -11.31 | Upgrade
|
| Interest & Investment Income | 168.9 | 168.9 | 100.3 | 31.2 | 6.8 | 6.87 | Upgrade
|
| Other Non Operating Income (Expenses) | 13 | -30 | -38.2 | -28 | -33.4 | -47.86 | Upgrade
|
| EBT Excluding Unusual Items | 2,038 | 1,673 | 1,181 | 848.4 | 50 | 492.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | -11.7 | -11.7 | -8.7 | -57.7 | -7.1 | -10.14 | Upgrade
|
| Pretax Income | 2,026 | 1,661 | 1,172 | 790.7 | 42.9 | 481.92 | Upgrade
|
| Income Tax Expense | 514.6 | 421.5 | 310.3 | 204.5 | 19.6 | 45.68 | Upgrade
|
| Net Income | 1,512 | 1,240 | 861.5 | 586.2 | 23.3 | 436.24 | Upgrade
|
| Net Income to Common | 1,512 | 1,240 | 861.5 | 586.2 | 23.3 | 436.24 | Upgrade
|
| Net Income Growth | 34.20% | 43.89% | 46.96% | 2415.88% | -94.66% | 53.53% | Upgrade
|
| Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| EPS (Basic) | 16.49 | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | Upgrade
|
| EPS (Diluted) | 16.49 | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 | Upgrade
|
| EPS Growth | 34.19% | 43.87% | 47.07% | 2456.00% | -94.75% | 53.53% | Upgrade
|
| Free Cash Flow | - | 1,308 | 998.9 | 648.2 | 58.5 | 455.33 | Upgrade
|
| Free Cash Flow Per Share | - | 14.26 | 10.90 | 7.07 | 0.64 | 4.97 | Upgrade
|
| Dividend Per Share | - | 4.500 | 3.000 | 2.500 | - | - | Upgrade
|
| Dividend Growth | - | 50.00% | 20.00% | - | - | - | Upgrade
|
| Gross Margin | 57.87% | 59.51% | 57.86% | 54.30% | 46.90% | 53.68% | Upgrade
|
| Operating Margin | 14.13% | 12.41% | 10.22% | 9.59% | 1.25% | 6.55% | Upgrade
|
| Profit Margin | 11.30% | 9.96% | 7.84% | 6.60% | 0.38% | 5.25% | Upgrade
|
| Free Cash Flow Margin | - | 10.51% | 9.09% | 7.30% | 0.95% | 5.48% | Upgrade
|
| EBITDA | 2,259 | 1,907 | 1,477 | 1,160 | 371 | 843.53 | Upgrade
|
| EBITDA Margin | 16.89% | 15.32% | 13.44% | 13.06% | 6.05% | 10.15% | Upgrade
|
| D&A For EBITDA | 369.4 | 362.8 | 354 | 308.3 | 294.4 | 299.17 | Upgrade
|
| EBIT | 1,889 | 1,545 | 1,123 | 851.3 | 76.6 | 544.36 | Upgrade
|
| EBIT Margin | 14.13% | 12.41% | 10.22% | 9.59% | 1.25% | 6.55% | Upgrade
|
| Effective Tax Rate | 25.40% | 25.37% | 26.48% | 25.86% | 45.69% | 9.48% | Upgrade
|
| Revenue as Reported | 13,585 | 12,616 | 11,087 | 8,913 | 6,141 | 8,315 | Upgrade
|
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.